| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
| mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
3e-05 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
4e-05 |
| mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
4e-05 |
| mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
5e-05 |
| mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
6e-05 |
| mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.22 |
7e-05 |
| mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
7e-05 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
8e-05 |
| mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
9e-05 |